These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27727000)

  • 1. Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis.
    Ku YH; Chuang YC; Yu WL
    J Formos Med Assoc; 2017 May; 116(5):404-405. PubMed ID: 27727000
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
    Kim SH; Kim MN; Lee SO; Choi SH; Kim YS; Woo JH; Lim CM; Koh Y; Hong SB
    Mycoses; 2012 Mar; 55(2):189-92. PubMed ID: 22004266
    [No Abstract]   [Full Text] [Related]  

  • 3. First Documented Case of Influenza A (H3N2 Subtype) Infection in a Patient With Complete Interferon Gamma Receptor 1 Deficiency: A Call for Systemic Vaccination Strategies.
    Olbrich P; Falcón-Neyra L; Molinos-Quintana A; Aguero-Sánchez M; Neth O
    Pediatr Infect Dis J; 2016 Jun; 35(6):712-3. PubMed ID: 27171582
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
    Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
    Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient.
    Cohen-Daniel L; Zakay-Rones Z; Resnick IB; Shapira MY; Dorozhko M; Mador N; Greenbaum E; Wolf DG
    J Clin Virol; 2009 Feb; 44(2):138-40. PubMed ID: 19157971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 39-2015. A 22-Year-Old Man with Hypoxemia and Shock.
    Shenoy ES; Lai PS; Shepard JA; Kradin RL
    N Engl J Med; 2015 Dec; 373(25):2456-66. PubMed ID: 26672848
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease.
    Carfagna P; Brandimarte F; Caccese R; Campagna D; Brandimarte C; Venditti M
    Mycoses; 2011 Nov; 54(6):549-51. PubMed ID: 21605188
    [No Abstract]   [Full Text] [Related]  

  • 9. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simply influenza A (H3N2)-associated encephalitis with seizure.
    Yuan HT; Ho TH; Lee JT; Chen PC; Wang CW; Yang FC
    Am J Emerg Med; 2019 Sep; 37(9):1808.e1-1808.e3. PubMed ID: 31230923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A (H1N1) in a pediatric patient with newly diagnosed acute promyelocytic leukemia and invasive pulmonary aspergillosis.
    Vallero S; Carraro F; Fagioli F; Postini AM; Rivetti E; Bezzio S; Giacchino M
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):562-4. PubMed ID: 21941151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    Minchole E; Figueredo AL; Omeñaca M; Panadero C; Royo L; Vengoechea JJ; Fandos S; de Pablo F; Bello S
    PLoS One; 2016; 11(11):e0165711. PubMed ID: 27832114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
    Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
    J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.
    Tselios K; Tsioka R; Sarantopoulos A; Mouloudi E; Boura P
    BMC Infect Dis; 2011 Dec; 11():358. PubMed ID: 22206235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of ozeltamivir (Tamiflu) in adult influenza on the epidemic rise of morbidity in Russia in the 2006-2007 season].
    Kolobukhina LV; Merkulova LN; Burtseva EI; Isaeva EI; Shchelkanov MIu; Beliakova NV; Grebennikova TV; Polikushina OE; Rotanov M; Malyshev NA; L'vov DK
    Vopr Virusol; 2008; 53(4):23-6. PubMed ID: 18756812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy.
    Sevketoglu E; Kural B; Beskardes AE; Hatipoglu S
    Ann Trop Paediatr; 2011; 31(1):93-6. PubMed ID: 21262116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 18. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
    Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
    Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.